end-to-end diagnostics implementation: advocating for innovative solutions
Published 1 year ago • 46 plays • Length 1:33:42Download video MP4
Download video MP3
Similar videos
-
13:31
s2-07: vrc01 antibody prevention of hiv
-
41:48
dolutegravir safety: new evidence and updated guidance on antiretroviral treatment for women
-
11:25
tuaa0104 - primary resistance against dolutegravir decreases hiv integration
-
22:07
dual therapy with dolutegravir and lamivudine | pedro cahn, md, phd (original)
-
14:47
pharmacology - hiv antiretroviral drugs (classes, mechanism of action and side effects)
-
2:55
toward a more precise medicine in liver disease
-
1:17:35
optimizing antiviral outcomes through clinical pharmacology
-
28:23
immunomodulatory strategies to control tb & implications for tb/hiv- dan kalman (emory university)
-
11:20
#1 - first pharmacokinetic data of dolutegravir in combination with a taf (...) - lisanne bevers
-
59:41
u3 webinar: targeted strategies to address gender disparities in care utilization for hiv
-
1:02
does an antibody need to be validated in multiple applications to prove specificity?
-
12:11
tuab0105 - raltegravir for prevention of mother-to-child transmission of hiv
-
2:43
integration of data toward precision medicine
-
2:36
a cd38-targeting bispecific antibody in the treatment of r/r t-all
-
16:18
dolutegravir (tivicay): a next generation integrase inhibitor
-
1:36
dolutegravir: a milestone in the fight against hiv in kenya (short version)
-
3:42
dolutegravir: a milestone in the fight against hiv in kenya
-
15:13
moaa0202 - treatment with anti-α4β7 integrin antibody reduces virus-mediated ...
-
11:19
la seguridad y eficacia del tar a base de dolutegravir entre pacientes con tb y coinfección por vih